Neonatal Estimation Of Brain Damage Risk And Identification of Neuroprotectants (NEOBRAIN)

H

Hannover Medical School (MHH)

Status

Completed

Conditions

Brain Damage, Chronic

Study type

Observational

Funder types

Other

Identifiers

NCT00544895

LSHM-CT-2006-036534

Details and patient eligibility

About

NEOBRAIN brings together small and medium sized enterprises (SMEs), industry and academic groups devoted to the diagnosis, management, and neuroprotection in newborns with perinatal brain damage. The focus of NEOBRAIN is to identify strategies prevention of brain damage mainly observed in preterm newborns. (Copy from www.neobrain.eu)

Enrollment

600 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: